-
5 medtech notes: Orthofix, ZimVie and more
Here are five key developments from spine devicemakers since Feb. 28. -
Orthofix sees 64% increase in Q4 revenue
Orthofix's fourth quarter sales grew 64%, and its full year revenue rose 62%, according to financial results posted March 5. -
2 spine companies launching public offering
Two spine companies launched public offerings since Feb. 26. -
Alphatec CFO sells 121K shares of stock
Alphatec CFO John Koning sold 121,601 shares of company stock on March 1, according to SEC documents. -
OrthoPediatrics launches new scoliosis treatment system
OrthoPediatrics has launched a new system, the Response rib and pelvic fixation system, to treat children with early onset scoliosis. -
Medtronic named among world's 'most ethical' companies
Orthopedic and spine tech manufacturer Medtronic has been named among the world's most ethical companies by for-profit ethical standards company the Ethisphere Institute. -
Stryker, Zimmer Biomet, J&J execs among the most 'influential' in healthcare
CEOWorld Magazine released its latest list of "World's Most Influential CEOs and Business Executives," and three orthopedic devicemaker leaders are on it. -
3 spine, orthopedic devices earning FDA nods
Here are three spine and orthopedic devices that have earned FDA clearance that Becker's has reported on since Feb. 22: -
Orthofix realigns spine business, names bone growth therapies leader
Orthofix is realigning its spine business unit effective March 1, and the company named Jason Shallenberger as president of the bone growth therapies business. -
Spineart completes enrollment for cervical disc trial
Spineart completed enrollment for the U.S. investigational device exemption trial with the Baguera C cervical disc implant, the devicemaker said Feb. 29. -
Woven Orthopedics gets 2nd FDA clearance for Ogmend
Woven Orthopedics earned its second FDA 510(k) clearance for the Ogmed implantable sleeve, the company said Feb. 29. -
ZimVie's 2023 spine sales fall 9% ahead of sale
ZimVie posted spine sales decreases in the fourth quarter and full year ahead of its planned sale of the business segment. -
Nevro earns FDA clearance for SI joint fixation system
Nevro earned FDA 510(k) clearance to use its sacroiliac joint fixation system without having to include a lateral screw, the devicemaker said Feb. 28. -
4 medtech notes: Alphatec, Smith+Nephew and more
Here are four key developments from spine and orthopedic devicemakers since Feb. 21. -
Alphatec CEO aspires to building 'spine monster' on the heels of strong 2023
Alphatec CEO Pat Miles has big expectations for the company after a strong 2023. -
Smith+Nephew records $5.5B in 2023 revenue
Medtech company Smith+Nephew surpassed $5 billion in 2023 revenue, according to its Feb. 27 financial report. -
SI-Bone sees 'year of records' in 2023
Spine devicemaker SI-Bone saw $138.9 million in revenue in 2023, the company said Feb. 26. -
Aclarion announces $3M public offering
Aclarion, a company focused on spine pain diagnostics, listed a $3 million public offering, the company said Feb. 26. -
4 patent lawsuits to know
In the last 11 months, several orthopedic and spine devicemakers have gone to court to defend their patents. -
10 spine device companies to watch in 2024
Spine devicemakers took important steps forward in innovation in 2023, and many are gearing up for exciting plans in the months ahead.
Page 2 of 189